NFKB1 and cancer: To determine whether other NF-κB pathway components were altered in the high NF-κB group, we performed pathway-oriented mutational analysis, examining a set of 9 NF-κB genes reported to be altered in other NF-κB-driven cancers (Fig. 4C).